NeuroNOS-1
Autism Spectrum Disorder
PreclinicalActive
Key Facts
About NeuroNOS
Israeli biotech targeting ASD core symptoms via nNOS inhibition to reduce nitrosative stress.
View full company profileTherapeutic Areas
Other Autism Spectrum Disorder Drugs
| Drug | Company | Phase |
|---|---|---|
| NTI164 | Neurotech International | Phase 3 |
| Exo‑Autism | Advancells | Phase 1 |
| Autism Program | Ignite Biomedical | Discovery |
| Kingdom Therapeutics Collaboration | Celadon Pharmaceuticals | Pre-clinical |
| MDXX‑2 | PharmAla Biotech | Preclinical |
| Banked Cord Blood Stem Cells | Cryo-Cell | Clinical Trials |